Filing Details

Accession Number:
0001628280-24-028993
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-06-18 21:45:33
Reporting Period:
2024-06-17
Accepted Time:
2024-06-18 21:45:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1771910 Adc Therapeutics Sa ADCT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1656998 Robert Azelby 430 Mountain Avenue, Suite 404
New Providence NJ 07974
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Disposition 2024-06-17 6,995 $2.89 53,005 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents Common Shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units.